Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for WAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -124.00M
March 31, 2026 -213.00M
December 31, 2025 26.66M
September 30, 2025 -66.27M
June 30, 2025 -1.028M
March 31, 2025 -173.25M
December 31, 2024 -193.58M
September 30, 2024 -176.88M
June 30, 2024 -34.04M
March 31, 2024 -292.18M
December 31, 2023 -130.49M
September 30, 2023 -113.52M
June 30, 2023 1.158B
March 31, 2023 -159.21M
December 31, 2022 -111.45M
September 30, 2022 -88.01M
June 30, 2022 -82.77M
March 31, 2022 -227.41M
December 31, 2021 -254.37M
September 30, 2021 -135.72M
June 30, 2021 -236.97M
March 31, 2021 188.78M
December 31, 2020 -172.53M
September 30, 2020 -108.60M
June 30, 2020 -192.28M
Date Value
March 31, 2020 32.92M
December 31, 2019 -211.14M
September 30, 2019 -366.81M
June 30, 2019 -571.60M
March 31, 2019 -723.13M
December 31, 2018 -493.08M
September 30, 2018 -256.21M
June 30, 2018 -364.17M
March 31, 2018 -1.006B
December 31, 2017 -24.38M
September 30, 2017 -17.21M
June 30, 2017 -9.922M
March 31, 2017 -12.36M
December 31, 2016 -35.04M
September 30, 2016 -1.913M
June 30, 2016 -27.50M
March 31, 2016 -37.40M
December 31, 2015 -11.68M
September 30, 2015 -9.366M
June 30, 2015 11.72M
March 31, 2015 -60.27M
December 31, 2014 -2.437M
September 30, 2014 -39.11M
June 30, 2014 -25.37M
March 31, 2014 -40.30M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 471.00M
Thermo Fisher Scientific, Inc. -1.571B
Danaher Corp. 7.273B
Revvity, Inc. -23.16M
Illumina, Inc. -129.00M